Loading news...
CROX, NESR and PHG stand out on broker upgrades as markets stay volatile, signaling potential upside despite geopolitical tensions and shifting investor sentiment.
VIENNA--(BUSINESS WIRE)-- #ambientai--Speech Processing Solutions launches Philips SpeechLive Health AI Assistant to convert clinical conversations into structured documentation.
March 20th, Philips Sonicare invites New Yorkers to rethink their nightly clean with an inside look at what happens in your mouth while you sleep CAMBRIDGE, Mass., March 17, 2026 /PRNewswire/ -- R oyal Philips (NYSE: PHG, AEX: PHIA) and its Sonicare brand, the #1 Dental Professional recommended sonic toothbrush brand worldwide, is marking World Oral Health Day by declaring it World Oral Health Night drawing attention to a common risk to your oral health many people overlook: assuming manual brushing always removes enough plaque.
Dimensional Fund Advisors LP cut its stake in Koninklijke Philips N.V. (NYSE: PHG) by 1.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,439,747 shares of the technology company's stock after selling 56,606 shares during the period. Dimensional
March 11, 2026 Fully cloud ‑ enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows. Philips IntelliSite Pathology Solution on HealthSuite¹, powered by Amazon Web Services (AWS) is a fully cloud-enabled digital pathology solution that helps pathology laboratories adopt and scale digital workflows without the complexity of on-premise infrastructure.
ARW, VSCO, GCT, EFXT and PHG have been added to the Zacks Rank #1 (Strong Buy) List on March 11th, 2026.
PHG, SUHJY and JPM made it to the Zacks Rank #1 (Strong Buy) income stocks list on March 11th, 2026.
March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and across specialties. By connecting clinical signals with diagnostic information, Philips enables care teams to move from fragmented data to a more continuous, actionable understanding of the patient.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
PHG unveils Rembra CT scanner, delivering 106 images per second and up to 270 scans daily, helping hospitals manage heavy imaging demand and speed diagnostics.
March 4, 2026 CE Marked and 510(k) pending, Rembra's advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real time With the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging and trauma, helping to improve comfort for complex patients and may reduce the need for rescans Next-generation NanoPanel Precise XD detector with AI is built for dose-efficient, high-resolution imaging to support clear visualization and delineation of anatomical structures Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced Rembra [3], its next-generation radiology CT system designed for the realities of acute and high-demand imaging. Rembra will be showcased publicly for the first time at ECR 2026 in Vienna.
March 3, 2026 With a total budget of EUR 21.5 million, the four-year SHERPA research project is coordinated by Philips and co-funded by the EU Innovative Health Initiative (IHI) and industry partners The project focuses on developing automated workflows for minimally invasive neurovascular and tumor treatments – clinical procedures where staffing levels and specialized expertise are in short supply The clinical studies are being conducted at University Medical Center Utrecht, St Antonius Hospital, University Medical Center Hamburg-Eppendorf, Hôpital Bicêtre AP-HP, and Hospital de la Santa Creu i Sant Pau On March 4 (16:30 - 17:30 CET), SHERPA will be featured at the European Congress of Radiology 2026 in a dedicated session Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Philips-coordinated SHERPA research consortium has initiated seven clinical studies to demonstrate the benefits of AI- and robotics-assisted workflows in minimally invasive treatments for brain aneurysms* and liver tumors. Staff shortages, coupled with the complex nature of the work, place significant pressure on interventional radiologists and interventional neuroradiologists who perform these procedures.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
February 19, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips' Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
February 12, 2026 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality imaging for clinicians.
PHG swings to Q4 profit as comparable sales jump 7% and orders rise, but shares fall despite double-digit EBITA growth and 2026 outlook.
February 11, 2026 Co-funded by the EU's Innovative Health Initiative (IHI), the research consortium is coordinated by Philips, together with Erasmus MC as academic lead, and will combine advanced medical imaging and minimally invasive techniques to transform treatment of bleeding and tumors in the brain Five-year research program with total budget of EUR 38.4 million includes eight clinical studies to validate technical solutions for minimally invasive neurosurgery Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the SEISMIC research consortium, coordinated by Philips, together with Erasmus MC as academic lead, has been awarded funding from the Innovative Health Initiative (IHI) to transform neurosurgery through the seamless integration of minimally invasive surgical techniques and advanced imaging technologies. The EUR 23.5 million public funding will be complemented by EUR 14.9 million in in-kind contributions and additional resources from industry partners, supporting a five-year research and innovation program that also includes eight clinical studies.
ABC Arbitrage SA decreased its holdings in Koninklijke Philips N.V. (NYSE: PHG) by 79.1% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund owned 50,362 shares of the technology company's stock after selling 190,099 shares during the quarter. ABC Arbitrage SA's holdings in Koninklijke
Koninklijke Philips N.V. (PHG) Q4 2025 Earnings Call Transcript